Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells

BACKGROUND: AZD3514 inhibits and down regulates the androgen receptor (AR) and has undergone clinical trials in prostate cancer. To provide proof-of-mechanism (POM) in patients, an immunohistochemistry (IHC) method for determination of AR in circulating tumour cells (CTC) was developed and validated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cummings, Jeffrey, Sloane, Robert, Morris, Karen, Zhou, Cong, Lancashire, Matt, Moore, David, Elliot, Tony, Clarke, Noel, Dive, Caroline
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Technical Advance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3977890/
https://ncbi.nlm.nih.gov/pubmed/24674711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-226
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars